North Point Portfolio Managers’s Boston Scientific BSX Stock Holding History

North Point Portfolio Managers’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.72M	Sell	108,023 -26,202	-20%	-$1.21M	0.79%	40
2026 Q2	$5.73M	Sell	134,225 -13,102	-9%	-$711K	0.95%	38
2026 Q1	$9.24M	Buy	147,327 +43,893	+42%	+$3.51M	1.65%	33
2025 Q4	$9.86M	Buy	+103,434	New	+$10.1M	1.67%	31

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

FFM

Fisher Funds Management Auckland, New Zealand $3.44B AUM 17.27% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

North Point Portfolio Managers's BSX Position: Q3 2026 in Review

North Point Portfolio Managers reduced its Boston Scientific (BSX) stake by 20% in Q3 2026, selling an estimated $1.21M and leaving 108,023 shares worth $4.72M. The position accounts for 0.79% of the portfolio, ranked #40.

North Point Portfolio Managers first reported a position in BSX in Q4 2025 and has held it in 4 quarters since. The position peaked at $9.86M in Q4 2025. 156 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

North Point Portfolio Managers held 108,023 shares of Boston Scientific worth $4.72M as of Q3 2026.
North Point Portfolio Managers sold 26,202 Boston Scientific shares in Q3 2026, an estimated $1.21M.
Boston Scientific made up 0.79% of North Point Portfolio Managers's portfolio in Q3 2026, its #40 holding.
North Point Portfolio Managers first reported a position in Boston Scientific in Q4 2025 and has held it in 4 quarters since.
North Point Portfolio Managers's Boston Scientific position peaked at $9.86M in Q4 2025.
156 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on North Point Portfolio Managers's 13F filing for Q3 2026, filed 7 Oct 2026.